ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 97 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $665,787 | +1413.2% | 67,048 | +511.5% | 0.00% | – |
| Q2 2022 | $44,000 | -65.1% | 10,964 | -61.2% | 0.00% | -100.0% |
| Q1 2022 | $126,000 | -69.0% | 28,292 | -72.1% | 0.00% | 0.0% |
| Q4 2021 | $406,000 | +2.5% | 101,479 | +124.9% | 0.00% | 0.0% |
| Q3 2021 | $396,000 | +91.3% | 45,127 | +147.0% | 0.00% | 0.0% |
| Q2 2021 | $207,000 | -29.1% | 18,269 | -53.6% | 0.00% | -75.0% |
| Q3 2020 | $292,000 | -52.0% | 39,349 | -73.0% | 0.00% | -60.0% |
| Q2 2020 | $608,000 | +710.7% | 145,690 | +377.5% | 0.01% | +400.0% |
| Q1 2020 | $75,000 | -76.9% | 30,508 | -50.6% | 0.00% | -33.3% |
| Q3 2019 | $325,000 | -56.3% | 61,695 | -50.3% | 0.00% | -57.1% |
| Q2 2019 | $744,000 | +9.4% | 124,038 | +64.7% | 0.01% | 0.0% |
| Q1 2019 | $680,000 | +20.1% | 75,304 | +10.4% | 0.01% | 0.0% |
| Q4 2018 | $566,000 | +251.6% | 68,205 | +482.9% | 0.01% | +250.0% |
| Q3 2018 | $161,000 | +1.3% | 11,700 | -47.0% | 0.00% | -33.3% |
| Q3 2017 | $159,000 | – | 22,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |